Our General Manager Ahmet Eren Sayın participated as an invited speaker at the international conference supported by the Georgian Medical Association and chaired by Ana Pantsulaia, Head of the Molecular Diagnostics and Oncogenetics Laboratory at Todua Clinic. He shared his experiences with scientists and doctors from various countries, establishing himself as a leading user in the field.
Held on June 15th in Tbilisi, Georgia, the meeting brought together numerous healthcare professionals specializing in molecular oncology. Our General Manager, Ahmet Eren Sayın, shared insights into the technologies we use in the next generation oncology and our experiences with Comprehensive Genomic Profiling (CGP) test, powered by Thermo Fisher Scientific's Oncomine™ Comprehensive Assay Plus (OCA Plus).
During his presentation, Ahmet Eren SAYIN highlighted case studies demonstrating how the identification of clinical biomarkers such as TMB, MSI, LOH, HRD, key variants, and fusions can guide clinicians in providing personalized diagnoses and treatments, including tailored immunotherapy solutions.
Here are some key features of our OnkoGenetiks® CGP test:
· Low DNA Input: Requires only 10-30 ng of DNA.
· Minimal Re-testing/Re-sampling: Less than 2%.
· Comprehensive Analysis: Covers 513 genes (DNA) and 49 genes (RNA).
· Biomarker Detection: Identifies SNVs, CNVs, MSI and TMB analysis.
· Fusion Gene Analysis: 1311 known fusion isoforms.
· HRD Detection: Identifies genomic instability in 46 key genes.
At GENETİKS GLOBAL, we are dedicated to advancing personalized cancer treatment through next generation genetic diagnostics. Our use of the OCA Plus solution allows us to provide in-depth analysis of tumor tissue samples, offering tailored and targeted treatment options for patients with urgent medical needs such as Breast-Ovarian Cancer, Pancreatic Cancer, Colorectal Cancer, Lung Cancer.
We are excited about the future of personalized medicine and the transformative role advanced molecular profiling will play in patient care.
In addition to Next Generation Oncology, we offer a wide range of comprehensive services, including:
- Preimplantation Genetic Testing (PGT)
- Targeted Oncology
- Non-Invasive Prenatal Test (NIPT24)
- Exome & Genome Sequencing (WES &WGS)
- CytoGenetics & FISH
- Molecular Genetics
- Pharmacogenetics
- GeneSports and NutriGenetiks
- Genetic Consultation